<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03194022</url>
  </required_header>
  <id_info>
    <org_study_id>IDRCB : 2017-A01801-52</org_study_id>
    <nct_id>NCT03194022</nct_id>
  </id_info>
  <brief_title>Biological Consequences of an Ultra Endurance Race</brief_title>
  <acronym>TRAIL-BIO</acronym>
  <official_title>Per Effort Study of Biological Consequences of an Ultra Endurance Race (165km)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital Necker-Enfants Malades</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital Necker-Enfants Malades</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to study per and post-exertion variations of biological markers during an
      ultra-endurance race
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      25 healthy adult volunteers participating in the &quot;100 miles South of France 2017©&quot; race
      recruited electronically by an announcement on the race website
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 6, 2017</start_date>
  <completion_date type="Anticipated">October 13, 2017</completion_date>
  <primary_completion_date type="Anticipated">October 6, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Per and post-exertion evolution of sodium blood level</measure>
    <time_frame>Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the race</time_frame>
    <description>Change of sodium blood level during and after the race will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Per and post-exertion evolution of lactatemia</measure>
    <time_frame>Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the race</time_frame>
    <description>Change of lactatemia during and after the race will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Per and post-exertion evolution of myoglobin blood level</measure>
    <time_frame>Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the race</time_frame>
    <description>Change of myoglobin blood level will be measured during and after the race</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Per and post-exertion evolution of creatinine phosphokinase blood level</measure>
    <time_frame>Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the race</time_frame>
    <description>Change of myoglobin blood level will be measured during and after the race</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Per and post-exertion evolution of potassium blood level</measure>
    <time_frame>Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the race</time_frame>
    <description>Change of potassium blood level during and after the race will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Per and post-exertion evolution of chlorine blood level</measure>
    <time_frame>Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the race</time_frame>
    <description>Change of chlorine blood level during and after the race will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Per and post-exertion evolution of glucose blood level</measure>
    <time_frame>Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the race</time_frame>
    <description>Change of glucose blood level during and after the race will be measured.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Per and post-exertion evolution of calcium blood level</measure>
    <time_frame>Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the race</time_frame>
    <description>Change of calcium blood level during and after the race will be measured.</description>
  </primary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Exertion; Excess</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sample</intervention_name>
    <description>measurement of electrolytes and blood count</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood electrolytes
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        25 healthy adult volunteers participating in the &quot;100 miles South of France 2017 ©&quot; race
        recruited electronically by an announcement on the race website
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age greater 18 years.

          2. Subject having already completed an ultra-endurance race (distance greater than 50
             kilometers) during the 24 months preceding the race.

          3. Affiliation of a social security.

        Exclusion Criteria:

          1. Age lower than 18 years

          2. Subjects with a medical history (pulmonary pathology, cardiac, hypertension) or having
             a significant chronic inflammatory disease known at the time of the inclusion visit
             the day before the race.

          3. Female
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2017</study_first_submitted>
  <study_first_submitted_qc>June 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2017</study_first_posted>
  <last_update_submitted>June 19, 2017</last_update_submitted>
  <last_update_submitted_qc>June 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hôpital Necker-Enfants Malades</investigator_affiliation>
    <investigator_full_name>Romain Jouffroy</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

